Cetuximab N01
Clinical trials for Cetuximab N01 explained in plain language.
Never miss a new study
Get alerted when new Cetuximab N01 trials appear
Sign up with your email to follow new studies for Cetuximab N01, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Triple-Drug combo shrink Hard-to-Treat colorectal tumors before surgery?
Disease control Recruiting nowThis phase 2 trial tests whether giving a combination of targeted drugs and chemotherapy before surgery can improve outcomes for people with a specific type of colorectal cancer that has a BRAF V600E mutation. Participants receive encorafenib, cetuximab, and mFOLFOX6 for eight we…
Matched conditions: CETUXIMAB N01
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Chemo-Free combo shows promise for Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis phase 2 trial tests two drugs, fulzerasib and cetuximab N01, given before surgery to people with a specific genetic subtype (KRAS G12C mutation) of locally advanced colorectal cancer. The goal is to shrink tumors and improve surgical outcomes without using chemotherapy. Fort…
Matched conditions: CETUXIMAB N01
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC